Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture

Journal of Virology

Volumn 87, Issue 3, 2013, Pages 1759-1769

  Sadeghipour, Sara ^a   Bek, Emily J ^a   McMinn, Peter C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GUANIDINE; NONSTRUCTURAL PROTEIN 3D; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS DNA;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIVIRAL RESISTANCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; ENTEROVIRUS 71; GENE MUTATION; GENETIC CODE; GENOTYPE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS EXPRESSION; VIRUS GENOME; VIRUS INHIBITION; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIABILITY;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, VIRAL; ENTEROVIRUS A, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION RATE; RIBAVIRIN; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VIRUS REPLICATION;

EID: 84873023551     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02139-12     Document Type: Article

References (39)

1. Schmidt NJ, Lennette EH, Ho HH. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129:304-309.
2. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341:929-935.
3. McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107.
4. Hansen JL, Long AM, Schultz SC. 1997. Structure of the RNA-dependent RNA polymerase of poliovirus. Structure 5:1109-1122.
5. Kok CC, McMinn PC. 2009. Picornavirus RNA-dependent RNA polymerase. Int. J. Biochem. Cell Biol. 41:498-502.
6. Gong P, Peersen OB. 2010. Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 107:22505-22510.
7. Wu Y, Lou Z, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li X, Rao Z. 2010. Structures of EV71 RNA-dependentRNApolymerase in complex with substrate and analogue provide a drug target against the hand-footand-mouth disease pandemic in China. Protein Cell 1:491-500.
8. Vignuzzi M, Stone JK, Andino R. 2005. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res. 107:173-181.
9. Graci JD, Cameron CE. 2006. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 16:37-48.
10. Pfeiffer JK, Kirkegaard K. 2003. A single mutation in poliovirus RNAdependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. U. S. A. 100:7289-7294.
11. Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, Wang J, Zhang C, Cao Q, Deng Y, Hu W, Yao K. 2012. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch. Virol. 157:669-679.
12. Crotty S, Cameron C, Andino R. 2002. Ribavirin's antiviral mechanism of action: lethal mutagenesis? J. Mol. Med. (Berl.) 80:86-95.
13. Crotty S, Maag D, Arnold JJ, Zhong W, Lau JY, Hong Z, Andino R, Cameron CE. 2000. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:1375-1379.
14. Arnold JJ, Vignuzzi M, Stone JK, Andino R, Cameron CE. 2005. Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J. Biol. Chem. 280:25706-25716.
15. Vignuzzi M, Wendt E, Andino R. 2008. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 14:154-161.
16. Pincus SE, Diamond DC, Emini EA, Wimmer E. 1986. Guanidineselected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J. Virol. 57:638-646.
17. Chua BH, Phuektes P, Sanders SA, Nicholls PK, McMinn PC. 2008. The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89:1622-1632.
18. McMinn P, Stratov I, Nagarajan L, Davis S. 2001. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in western Australia. Clin. Infect. Dis. 32: 236-242.
19. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27:493-497.
20. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348.
21. Pincus SE, Rohl H, Wimmer E. 1987. Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology 157:83-88.
22. Sadeghipour S, Bek EJ, McMinn PC. 2012. Selection and characterisation of guanidine-resistant mutants of human enterovirus 71. Virus Res. 169: 72-79.
23. Belsham GJ, Normann P. 2008. Dynamics of picornavirus RNA replication within infected cells. J. Gen. Virol. 89:485-493.
24. + protein with a coordinated ATP hydrolysis mechanism. J. Biol. Chem. 285:24347-24359.
25. Robins RK, Revankar GR, McKernan PA, Murray BK, Kirsi JJ, North JA. 1985. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin. Adv. Enzyme Regul. 24:29-43.
26. Smith RA, Kirkpatrick W (ed). 1980. Ribavirin: a broad spectrum antiviral agent. Academic Press, Inc., San Diego, CA.
27. Streeter DG, Witkowski JT, Khare GP, Sidwell RW, Bauer RJ, Robins RK, Simon LN. 1973. Mechanism of action of 1-μ-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad-spectrum antiviral agent. Proc. Natl. Acad. Sci. U. S. A. 70:1174-1178.
28. Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, Rassam S, Fryden A, Reesink H, Bassendine M, Norkrans G, Cuypers T, Lelie N, Telfer P, Watson J, Weegink C, Sillikens P, Weiland O. 1996. Ribavirin treatment for patients with chronic hepatitis C: results of a placebocontrolled study. J. Hepatol. 25:591-598.
29. Hultgren C, Milich DR, Weiland O, Sallberg M. 1998. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B andCvirus-specific immune responses. J. Gen. Virol. 79:2381-2391.
30. Mosmann TR, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138-146.
31. Tam RC, Ramasamy K, Bard J, Pai B, Lim C, Averett DR. 2000. The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels. Antimicrob. Agents Chemother. 44:1276-1283.
32. Zimmerman TP, Deeprose RD. 1978. Metabolism of 5-amino-1-μ-Dribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5=-triphosphates in human blood and L5178Y cells. Biochem. Pharmacol. 27:709-716.
33. Ferrer-Orta C, Agudo R, Domingo E, Verdaguer N. 2009. Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase. Curr. Opin. Struct. Biol. 19:752-758.
34. Ferrer-Orta C, Arias A, Agudo R, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N. 2006. The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J. 25:880-888.
35. Jiang H, Weng L, Zhang N, Arita M, Li R, Chen L, Toyoda T. 2011. Biochemical characterization of enterovirus 71 3D RNA polymerase. Biochim. Biophys. Acta 1809:211-219.
36. Thompson AA, Peersen OB. 2004. Structural basis for proteolysisdependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J. 23:3462-3471.
37. Gnädig NF, Beaucourt S, Campagnola G, Bordería AV, Sanz-Ramos M, Gong P, Blanc H, Peersen OB, Vignuzzi M. 2012. Coxsackievirus B3 mutator strains are attenuated in vivo. Proc. Natl. Acad. Sci. U. S. A. 109:E2294-E2303.
38. Gohara DW, Crotty S, Arnold JJ, Yoder JD, Andino R, Cameron CE. 2000. Poliovirus RNA-dependent RNA polymerase (3Dpol): structural, biochemical, and biological analysis of structural motifs A and B. J. Biol. Chem. 275:25523-25532.
39. Styczynski MP, Jensen KL, Rigoutsos I, Stephanopoulos G. 2008. BLOSUM62 miscalculations improve search performance. Nat. Biotechnol. 26:274-275.